EFFECTS OF CYCLOSPORINE ON SYSTEMIC MHC EXPRESSION

Authors:
  • PHPhilip F. Halloran
    Philip F. Halloran
  • SCSandra Cockfield
    Sandra Cockfield
  • PAPeter Autenried
    Peter Autenried
Publisher website
Google Scholar
Abstract
The ability of lipopolysaccharide to induce major histocompatibility complex hyperexpressionin vivoin a variety of mouse tissues—particularly kidney—and the effect of cyclosporine on this process were studied. MHC expression was measured by a radiolabeled antibody-binding assay using tissue homogenates, as well as by assessment of tissue sections by indirect immunoperoxidase staining. LPS administered to mice in two doses, 4 days apart, induced an increase in class I expression in several tissues but also induced an increase in class II expression in kidney. A similar increase in class II expression in kidney was not elicited with polyinosinic acid/polycytidylic acid, an agent that induces release of IFN-α/β and increases class I MHC product expression. Thus we reasoned that LPSin vivomay release IFN-γ, which then induces increased expression of MHC products. We validated this hypothesis by demonstrating that monoclonal antibody against IFN-γ inhibited the induction of renal MHC products by LPS. However, the LPS effects did not require the participation of T cells, being demonstrable in nude mice and in mice with severe combined immunodeficiency. Moreover, the effect of LPS on MHC expression in normal and nude mice was inhibited byin vivoadministration of monoclonal anti-body against IFN-γ just as it was in normal mice. Thus the class II hyperexpression that follows LPS is apparently mediated by non T cells and is due to the systemic release of IFN-γ. This mechanism was inhibited by high doses of CsAin vivo,both in normal and in nude mice. The results indicate that there is a non T cell pathway for IFN-γ release (and MHC induction)in vivothat is sensitive to CsA. This observation raises the possibility that some of the immunosuppressive effects of CsA may be due to inhibition of mediator release from non T cells.